NCT02146547
|
2015-02-01 |
European Long-acting Antipsychotics in Schizophrenia Trial
|
Phase 4
|
Not Yet Recruiting
|
NCT01947803
|
2013-09-01 |
A Safety and Effectiveness Study of Paliperidone Palmitate in Chinese Patients With Schizophrenia
|
Phase 4
|
Active, Not Recruiting
|
NCT01795547
|
2013-02-01 |
Aripiprazole Once-monthly Versus Paliperidone Palmitate in Adult Patients With Schizophrenia
|
Phase 3
|
Completed
|
NCT01685931
|
2012-11-01 |
A Study of Paliperidone Palmitate in Patients With Schizophrenia Previously Unsuccessfully Treated by Oral Antipsychotics
|
Phase 4
|
Active, Not Recruiting
|
NCT01458379
|
2012-08-01 |
Brain Myelination Effects of Paliperidone Palmitate Versus Oral Risperidone in First Episode Schizophrenia
|
Phase 4
|
Not Yet Recruiting
|
NCT01527305
|
2012-06-01 |
A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Subjects With Acute Schizophrenia
|
Phase 4
|
Completed
|
NCT01682161
|
2012-01-01 |
A Comparative Study to Evaluate the Evolution of Medication Satisfaction and Adherence in Patients Unsatisfied With Current Oral Atypical Antipsychotics by Switching Medication to Paliperidone Palmitate
|
Phase 4
|
Completed
|
NCT01476358
|
2011-11-01 |
Effect of Vitamin A Supplementation on Immune Responses in Human Neonates
|
Phase 2
|
Active, Not Recruiting
|
NCT01451736
|
2011-10-01 |
Oral Risperidone Versus Injectable Paliperidone Palmitate for Treating First-Episode Schizophrenia
|
Phase 4
|
Recruiting
|
NCT01448720
|
2011-09-01 |
Treatment of Patients With Recently Exacerbated Schizophrenia With Paliperidone Palmitate
|
Phase 3
|
Completed
|
NCT01860781
|
2011-08-01 |
The Effect of Paliperidone Palmitate in Schizophrenia
|
Phase 4
|
Recruiting
|
NCT01381276
|
2011-06-01 |
Vitamin A Absorption From Cassava in Women
|
Phase 2
|
Completed
|
NCT01362426
|
2011-03-01 |
Paliperidone Palmitate Effectiveness Assessment Registry - Longitudinal (PEARL)
|
Phase 4
|
Completed
|
NCT01136772
|
2011-02-01 |
A Comparison of Long-acting Injectable Medications for Schizophrenia
|
Phase 4
|
Active, Not Recruiting
|
NCT01281527
|
2010-11-01 |
Paliperidone Palmitate Flexible Dosing in Schizophrenia
|
Phase 3
|
Completed
|
NCT01299389
|
2010-10-01 |
An Efficacy and Safety Study of Paliperidone Palmitate in Participants With Schizophrenia
|
Phase 3
|
Completed
|
NCT01211704
|
2010-10-01 |
Paliperidone Palmitate Efficacy and Safety in Bipolar Disorder Complicated by Alcoholism
|
Phase 4
|
Withdrawn
|
NCT01258920
|
2010-10-01 |
A Study of Paliperidone Palmitate in Japanese Patients With Schizophrenia
|
Phase 3
|
Completed
|
NCT01193153
|
2010-09-01 |
A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
|
Phase 3
|
Completed
|
NCT01181960
|
2010-08-01 |
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
|
Phase 4
|
Completed
|
NCT01193166
|
2010-08-01 |
Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital
|
Phase 4
|
Withdrawn
|
NCT01157351
|
2010-05-01 |
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
|
Phase 4
|
Completed
|
NCT01051531
|
2010-04-01 |
A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to Patients With Schizophrenia
|
Phase 3
|
Completed
|
NCT01081769
|
2010-02-01 |
Prevention of Relapse With Injectable Paliperidone Palmitate Versus Oral Antipsychotics
|
Phase 3
|
Completed
|
NCT00946985
|
2009-06-01 |
28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years
|
Phase 4
|
Terminated
|
NCT01942382
|
2009-04-01 |
A Clinical Pharmacology Study of JNS010 (Paliperidone Palmitate) in Patients With Schizophrenia
|
Phase 1
|
Completed
|
NCT01559272
|
2008-02-01 |
A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Paliperidone Palmitate in Patients With Schizophrenia
|
Phase 1
|
Completed
|
NCT00604279
|
2008-01-01 |
A Comparative Study of Paliperidone Palmitate and Risperidone Long Acting Injection (LAI) in Participants With Schizophrenia
|
Phase 3
|
Completed
|
NCT01150448
|
2007-09-01 |
A Safety and Pharmacokinetic Study of Paliperidone Palmitate in Patients With Schizophrenia
|
Phase 1
|
Completed
|
NCT00589914
|
2007-03-01 |
Comparison of Paliperidone Palmitate and RISPERDAL CONSTA in Patients With Schizophrenia
|
Phase 3
|
Completed
|
NCT00590577
|
2007-03-01 |
Effectiveness and Safety of 3 Fixed Doses (25 mg eq., 100 mg eq., and 150 mg eq.) of Paliperidone Palmitate in Patients With Schizophrenia
|
Phase 3
|
Completed
|
NCT01606254
|
2007-01-01 |
A Pharmacokinetic and Safety Study of Paliperidone Palmitate (JNS010) in Participants With Schizophrenia
|
Phase 2
|
Completed
|
NCT00862368
|
2005-10-01 |
Sustaining Smoking Cessation in Smokers With Kids With Asthma
|
Phase 3
|
Completed
|
NCT01110317
|
2005-07-01 |
A Study of Paliperidone Blood Concentrations in Patients With Schizophrenia After Administration of Paliperidone Palmitate
|
Phase 1
|
Completed
|
NCT00119756
|
2005-06-01 |
A Safety and Tolerability Study of Paliperidone Palmitate Injected in the Shoulder or the Buttock Muscle in Patients With Schizophrenia
|
Phase 3
|
Completed
|
NCT00210548
|
2005-04-01 |
A Study to Evaluate the Effectiveness and Safety of 3 Doses of Paliperidone Palmitate in Treating Subjects With Schizophrenia
|
Phase 3
|
Completed
|
NCT00111189
|
2005-02-01 |
A Study of the Efficacy (Effectiveness) of Paliperidone Palmitate in the Prevention of Recurrence of the Symptoms of Schizophrenia.
|
Phase 3
|
Completed
|
NCT00210717
|
2005-02-01 |
A Study to Compare the Effectiveness and Safety of Flexibly Varied Doses of Paliperidone Palmitate and Risperidone in Treating Patients With Schizophrenia
|
Phase 3
|
Completed
|
NCT00101634
|
2004-12-01 |
Efficacy and Safety of a Long Acting Anti-Psychotic Versus Placebo in Patients With Schizophrenia
|
Phase 3
|
Completed
|
NCT00073320
|
2003-08-01 |
Intramuscular Injections of Paliperidone Palmitate in the Arm or Buttock of Subjects With Schizophrenia
|
Phase 3
|
Completed
|
NCT00198718
|
1997-11-01 |
Single-dose Postpartum Vitamin A Supplementation of Mothers and Neonates
|
Phase 2
|
Active, Not Recruiting
|